Skip to main content
Premium Trial:

Request an Annual Quote

GE, Hamilton Developing FTA Workflow

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –GE Health and Hamilton Robotics today announced a licensing agreement and collaboration to develop an automated workflow for sample handling and processing from FTA substrates.

The deal focuses on challenges in high-throughput dried sample processing for applications including drug metabolism and pharmacogenetics, and human identification, Richard Dool, GE Healthcare's general manager for consumables, said in a statement. By removing process bottlenecks, his firm and Hamilton hope to "establish a new standard in efficiency and reliability."

Terms of the deal were not disclosed.

According to Radi Hofstetter, vice president of the Hamilton facility in Bonaduz, Switzerland, FTA paper is becoming the method of choice in forensic sample collection, processing, and storage. "Incorporating this technology into an automated workflow will afford higher throughput and efficiencies within forensics as well as in new areas of application, including" drug metabolism and pharmacogenetics, he said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.